ATLASATLAS News · Deals
Windward Bio Lists on Nasdaq; Firmus Plans Raise After IPO Collapse
Windward Bio has listed on Nasdaq, per a company announcement in the Financial Times, while Bloomberg cites the AFR on Firmus's capital-raising plan.
What happened
The Financial Times published a company announcement saying that Windward Bio, a biotech focused on innovative immunology, has listed on Nasdaq.
Separately, Bloomberg reports, citing the Australian Financial Review (AFR), that Firmus plans to raise $3 billion after its IPO collapsed.
The sources provided give no further details on the terms of either transaction, the companies' valuations or the reasons behind the IPO collapse.
Context
Biotech companies often turn to public markets to fund research, and companies whose IPOs fall through sometimes look at other ways to raise capital.
Why it matters
The two items show contrasting conditions for capital-raising, which may interest those following listings and funding activity.
Sources
ATLAS writes its own summaries from the reporting of these outlets. Each link opens the original publisher.
- Innovative Immunology Biotech Windward Bio Lists on Nasdaq – Company Announcement · Financial Times · November 14, 2026
- Firmus Plans to Raise $3 Billion After IPO Collapse, AFR Says · Bloomberg.com · November 15, 2026
Related
- Union Pacific-Norfolk Southern Merger Paused as Farm Groups Object
- Brookfield to Buy Edmonton's Gregg Distributors for $1.6 Billion
- Union Pacific-Norfolk Southern deal spread widens after report on CEO remarks
- Anthropic IPO Set to Cap a Year of Record Equity Megadeals
- Marvell reportedly plans $115B Lumentum deal; its shares fall over 6%
What you get with ATLAS
Create my ATLAS account →Fair value, probabilities and earnings for every stock. Free account, no card. Information, not advice.
Information, not advice. This content is informational and is not an investment recommendation or an offer to buy or sell securities. ATLAS estimates come from statistical models using public data, can be wrong, and past performance does not guarantee future results. Disclaimer